Skip to main content
. Author manuscript; available in PMC: 2023 Dec 12.
Published in final edited form as: J Hypertens. 2023 Mar 3;41(5):751–758. doi: 10.1097/HJH.0000000000003396

Table 1.

Characteristics of participants included in the most complete measurement period, Q3–2018 to Q3–2019

Patient Characteristics (N=1,818,041) Distribution %

Age
18-44 8.9%
45-64 38.9%
65 and over 52.2%
Sex
Female 52.1%
Male 47.9%
Race/Ethnicity
White Non-Hispanic 69.8%
Black Non-Hispanic 14.1%
Asian Non-Hispanic 2.2%
Hispanic 8.6%
Other Race/Ethnicity 5.3%
Blood Pressure Stage at Baseline
Normal BP 16.3%
Elevated BP 15.2%
Stage1HTN 32.9%
Stage2HTN 31.9%
Missing1 3.7%
Comorbidities
Diabetes 28.0%
Coronary Artery Disease 17.3%
Heart Failure 6.4%
Region
East North Central (ENC) 24.6%
Northeast (NE) 19.4%
South (S) 17.2%
Southeast (SE) 15.6%
South West (SW) 12.6%
Central (C) 8.3%
West North Central (WNC) 1.7%
West (W) 0.4%
North West (NW) 0.2%
1

People with hypertension diagnosis who did not have both SBD and DBP measurements during the measurement period.